Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Indian exporters who built their businesses on Americans' demand for affordable goods are redrawing their strategies and ...

Gokaldas Exports Ltd., one of India’s largest apparel exporters that earns about 70% of its revenue from the US, plans to ...

Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or ...

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Indian exporters are scrambling to adapt as US President Trump's tariffs on Indian goods surge, potentially impacting India's ...